Medtronic Plc [MDT] stock prices are up 1.26% to $92.27 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The MDT shares have gain 2.53% over the last week, with a monthly amount glided 2.80%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Medtronic Plc [NYSE: MDT] stock has seen the most recent analyst activity on October 10, 2024, when RBC Capital Mkts upgraded its rating to a Outperform and also boosted its price target to $105 from $98. Previously, Oppenheimer reaffirmed its Perform rating on August 21, 2024, and elevated its price target to $94. On August 15, 2024, upgrade upgraded it’s rating to Neutral and revised its price target to $90 on the stock. Stifel downgraded its rating to a Hold and decreased its price target to $85 on August 14, 2024. Goldman initiated its recommendation with a Sell and recommended $83 as its price target on May 30, 2024. Robert W. Baird started tracking with a Neutral rating for this stock on July 19, 2023, and assigned it a price target of $90. In a note dated June 30, 2023, CL King initiated an Buy rating and provided a target price of $106 on this stock.
The stock price of Medtronic Plc [MDT] has been fluctuating between $68.84 and $92.25 over the past year. Currently, Wall Street analysts expect the stock to reach $107.91 within the next 12 months. Medtronic Plc [NYSE: MDT] shares were valued at $92.27 at the most recent close of the market. An investor can expect a potential return of 16.95% based on the average MDT price forecast.
Analyzing the MDT fundamentals
The Medtronic Plc [NYSE:MDT] reported sales of 32.58B for trailing twelve months, representing a surge of 2.77%. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at 0.18%, Pretax Profit Margin comes in at 0.15%, and Net Profit Margin reading is 0.12%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.08 and Total Capital is 0.07. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.58.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 91.17 points at the first support level, and at 90.07 for the second support level. However, for the 1st resistance point, the stock is sitting at 92.88, and for the 2nd resistance point, it is at 93.49.
Ratios To Look Out For
It’s worth pointing out that Medtronic Plc [NYSE:MDT]’s Current Ratio is 2.13. As well, the Quick Ratio is 1.61, while the Cash Ratio is 0.13. Considering the valuation of this stock, the price to sales ratio is 3.63, the price to book ratio is 2.47 and price to earnings (TTM) ratio is 31.04.
Transactions by insiders
Recent insider trading involved PARKHILL KAREN L, Former Director, that happened on Oct 23 ’24 when 23848.0 shares were purchased. Former BOD, PARKHILL KAREN L completed a deal on Oct 18 ’24 to buy 48825.0 shares. Meanwhile, Former BOD PARKHILL KAREN L bought 55179.0 shares on Oct 17 ’24.
